Skip to main content

TEVA 7166 (Celecoxib 200 mg)

Pill with imprint TEVA 7166 is White & Yellow, Capsule-shape and has been identified as Celecoxib 200 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Celecoxib is used in the treatment of ankylosing spondylitis; osteoarthritis; familial adenomatous polyposis; juvenile rheumatoid arthritis; migraine and belongs to the drug class cox-2 inhibitors. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7166

Celecoxib 200 mg TEVA 7166
Celecoxib 200 mg TEVA 7166
Celecoxib 200 mg TEVA 7166
Celecoxib 200 mg TEVA 7166
Celecoxib 200 mg TEVA 7166


TEVA 7166
200 mg
White & Yellow
Prescription only
Drug Class
Cox-2 inhibitors
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc
Inactive Ingredients
ferrosoferric oxide, gelatin, mannitol, povidone k30, propylene glycol, shellac, sodium lauryl sulfate, sodium stearyl fumarate, titanium dioxide, D&C Red No. 33, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-7166 Teva Pharmaceuticals USA, Inc.
42291-0194 (Discontinued) AvKare, Inc.
68084-0976 (Discontinued) Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.